Search clinical trials for: histologically or cytologically confirmed non-hematological
Total 204414 results
-
Intergroupe Francophone de Cancerologie ThoraciqueCompleted
-
National Cancer Institute (NCI)TerminatedPancreatic Neoplasms | Pancreatic Cancer | Metastatic Pancreatic Cancer | Histologically or Cytologically Confirmed Pancreatic Cancer | Unresectable or Borderline Resectable Pancreatic CancerUnited States
-
University of OxfordPfizer; Belfast Health and Social Care Trust; Queen's University, Belfast; Saint... and other collaboratorsCompletedColorectal Cancer | Solid TumorUnited Kingdom
-
OncoMed Pharmaceuticals, Inc.Novotech (Australia) Pty LimitedCompletedPancreatic CancerAustralia, New Zealand, Spain
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
National Cancer Institute (NCI)CompletedHistologically or Cytologically Confirmed Pancreatic Ca | Unresectable or Borderline Resectable Pancreatic CaUnited States
-
Cascadian Therapeutics Inc.CompletedMetastatic Cancer | Advanced CancerUnited States
-
Genzyme, a Sanofi CompanyCompletedNon Small Cell Lung CancerItaly
-
Centre Leon BerardCompletedMetastatic Renal Cell Carcinoma | Advanced Refractory Solid Tumors Histologically or Cytologically ConfirmedFrance
-
Synta Pharmaceuticals Corp.CompletedSolid TumorsUnited States
-
Synta Pharmaceuticals Corp.UnknownSolid TumorsUnited States
-
ImmuneOncia Therapeutics Inc.Not yet recruitingA Study of Phase2, IMC-001 In Patients With Metastatic Or Locally Advanced TMB-H Solid Tumor (TMB-H)TMB-H | Histologically or Cytologically Proven Metastatic or Locally Advanced Solid Tumors
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Centre Hospitalier Régional d'OrléansCompletedHuman Papilloma Virus Infection | Squamous Intraepithelial Lesions of the Cervix | Cervix LesionFrance
-
Abramson Cancer Center at Penn MedicineActive, not recruitingProstate AdenocarcinomaUnited States
-
Akero Therapeutics, IncActive, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
H. Lee Moffitt Cancer Center and Research InstituteHorizon Pharma Ireland, Ltd., Dublin IrelandCompletedBreast Cancer | Breast Cancer, Male | HER2-positive Breast Cancer | Breast Cancer FemaleUnited States
-
Galderma R&DCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteEisai Inc.CompletedBreast CancerUnited States
-
Akero Therapeutics, IncCompletedNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
Abramson Cancer Center of the University of PennsylvaniaCompletedMetastatic Adenocarcinoma | Advanced AdenocarcinomaUnited States
-
Yonsei UniversityActive, not recruitingHistologically Confirmed Unresectable or Metastatic Squamous Cell Carcinoma of the Esophagus Who Failed on Standard TreatmentKorea, Republic of
-
Novartis PharmaceuticalsTerminatedHistologically-proven and Radiologically-confirmed Solid TumorsItaly, New Zealand
-
Bristol-Myers SquibbCompletedMelanomaGermany, Italy, Sweden, United Kingdom, Belgium, Netherlands, Spain, Finland, Austria, Ireland, Poland, Portugal, Russian Federation, Switzerland, Czechia, Greece, Hungary, Luxembourg, Norway, Romania
-
OncoMed Pharmaceuticals, Inc.Celgene CorporationCompletedNonsquamous Nonsmall Cell Neoplasm of LungSpain, United States, Australia, Italy, Belgium
-
OncoMed Pharmaceuticals, Inc.Novotech (Australia) Pty LimitedCompletedColorectal CancerAustralia, New Zealand
-
Medstar Health Research InstitutePfizerCompletedPapillary Thyroid Cancer | Differentiated Thyroid Cancer | Follicular Thyroid CancerUnited States
-
Instituto Nacional de Cancerologia de MexicoCompletedPhase II Clinical Trial | Ninety-six Histologically Confirmed NSCLC Patients With BM | Randomized 1:1 to Received TN Plus WBR or Only WBR | ICPFS Evaluated by Two Blinded and Independent Radio-oncologist With MRIMexico
-
Karolinska University HospitalUllevaal University Hospital; Oslo University Hospital; Sahlgrenska University... and other collaboratorsCompletedCarcinoma, Squamous Cell | Adenocarcinoma of the Esophagus and Gastric CardiaSweden
-
Abramson Cancer Center of the University of PennsylvaniaWithdrawn
-
University Health Network, TorontoCompletedPreviously Untreated and Histologically Confirmed Stage III (Unresectable) or Stage IV MelanomaCanada
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Novartis PharmaceuticalsCompletedHead and Neck Neoplasms | Central Nervous System NeoplasmsUnited States
-
Intergroupe Francophone de Cancerologie ThoraciqueCompletedNon-small Cell Lung Cancer | ELDERLY PEOPLEFrance
-
University of UtahCompleted
-
Duke UniversityImmunotopeCompleted
-
National University Hospital, SingaporeCompleted
-
Chinese University of Hong KongCompletedNasopharyngeal Neoplasms | Epstein-Barr Virus InfectionsHong Kong
-
Alberta Health servicesCompleted
-
AmgenCompletedHistologically or Cytologically Documented Solid Tumors
-
Gruppo Italiano Studio LinfomiRegistro Tumori di Modena; Registro Tumori di Reggio Emilia; Registro Tumori... and other collaboratorsCompletedHistologically Confirmed Classical Hodgkin Lymphoma According to the Current World Health Organisation ClassificationItaly
-
AstraZenecaCompletedHead and Neck CancerSwitzerland
-
NovartisBayerCompletedNeoplasm Metastasis | TumorsUnited States
-
AstraZenecaTerminatedSubjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and III) and Histologically-Confirmed Intestinal GCFinland
-
Thallion PharmaceuticalsCompletedGlioma | Breast Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | TumorsCanada
-
Solvay PharmaceuticalsCompletedEndometriosisRussian Federation, Australia, Belgium, Bulgaria, Germany, Romania, South Africa, Ukraine
-
Boehringer IngelheimRecruitingObesity | Non-Alcoholic SteatoHepatitis (NASH)United States
-
Karolinska University HospitalRigshospitalet, Denmark; Sahlgrenska University Hospital, Sweden; University...RecruitingGall Bladder CancerSweden
-
AstraZenecaRecruiting
-
Mayo ClinicRecruitingOropharyngeal Human Papillomavirus-Positive Squamous Cell CarcinomaUnited States
-
AN2 Therapeutics, IncMahidol Oxford Tropical Medicine Research UnitRecruitingMelioidosisThailand, Lao People's Democratic Republic